Functional analysis of CD59 using complement-dependent cytotoxicity assay

Martin Kolev*

*Corresponding author for this work

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    1 Citation (Scopus)

    Abstract

    CD59 overexpression has been shown to confer the resistance of tumors to complement lysis. Complement lysis is one of the two major killing mechanisms of therapeutic anticancer antibodies. This chapter provides a method that allows studying the extent of complement protection of tumors by CD59.

    Original languageEnglish
    Title of host publicationThe Complement System: Methods and Protocols
    PublisherHumana Press Inc
    Pages347-353
    Number of pages7
    Volume1100
    ISBN (Print)9781627037235
    DOIs
    Publication statusPublished - 2014

    Publication series

    NameMethods in Molecular Biology
    Volume1100
    ISSN (Print)10643745

    Keywords

    • Anti-disialoganglioside GD2 antibody
    • Cancer
    • Cell lines
    • Complement-dependent cytotoxicity
    • Fab fragments
    • Normal human serum

    Fingerprint

    Dive into the research topics of 'Functional analysis of CD59 using complement-dependent cytotoxicity assay'. Together they form a unique fingerprint.

    Cite this